从怀疑到诊断:对疑似肌缩性侧面硬化症的探索策略
Maëlle Garnier1, Jean-Philippe Camdessanché2, Julien Cassereau1,3
1CRMR SLA, CHU d'Angers, Angers, France.
Annals of medicine
|September 5, 2024
概括
诊断肌缩侧面硬化症 (ALS) 由于患者的症状多样化和缺乏特定测试而具有挑战性. 准确的诊断需要临床专业知识来区分ALS和其他疾病,而不会延迟关键的治疗.
科学领域:
- 神经学 神经学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 肌缩侧面硬化症 (ALS) 诊断依赖于识别上下运动神经元退化与渐进的运动软弱.
- 尽管有明确的标准,但ALS诊断因不同的临床表现,疾病位置 (从中心到外围) 和症状分布而复杂化.
研究的目的:
- 为了突出动脉缩侧面硬化症 (ALS) 的诊断挑战.
- 强调需要整合临床,电生理学,生物和放射学数据的综合诊断策略.
- 强调识别多样化的ALS表型和差异诊断的重要性.
主要方法:
- 临床评估渐进的运动弱点.
- 电生理学研究评估神经和肌肉功能.
- 生物和放射学调查以支持诊断和排除模仿者.
- 综述各种临床表型和ALS的差异诊断.
主要成果:
- 由于广泛的临床表型,疾病进展率和症状局部化,ALS诊断是复杂的.
- 没有单一的诊断测试存在于ALS,需要一个多方面的方法.
- 区分ALS和模仿性需要仔细评估临床和准临床发现.
结论:
- 准确及时诊断ALS对于立即开始治疗至关重要.
- 对于临床医生来说,深入了解ALS表型和差异诊断是必不可少的.
- 诊断策略必须平衡彻底性与避免治疗延迟的需要.
更多相关视频
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
31.7K
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.8K
相关概念视频
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
